Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul T Kennedy

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|March 29, 2021
Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic ReviewGeorgia Wells, Paul T Kennedy, Lekh N Dahal
European Journal of Immunology|December 18, 2025
Mass Cytometry-Based Approach for the Investigation of Stimulator of Interferon Genes PathwayAnne Reversat, Paul T Kennedy, Anni Georghiou, et al.
Journal for Immunotherapy of Cancer|November 22, 2023
Neuroblastoma: an ongoing cold front for cancer immunotherapyPaul T Kennedy, Demetra Zannoupa, Meong Hi Son, et al.
Immunotherapy Advances|April 23, 2025
CTLA-4-two pathways to anti-tumour immunity?Frank J Ward, Paul T Kennedy, Farah Al-Fatyan, et al.
Cancer Research Communications|December 26, 2023
Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck CancersEmma L Saulters, Paul T Kennedy, Rachel J Carter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2023
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunityPaul T Kennedy, Emma L Saulters, Andrew D Duckworth, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 18, 2021
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent InflammationJack Rivers-Auty, Victor S Tapia, Claire S White, et al.
EMBO Molecular Medicine|June 23, 2018
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxiaDaniel E Foxler, Katherine S Bridge, John G Foster, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|March 29, 2021
Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic ReviewGeorgia Wells, Paul T Kennedy, Lekh N Dahal
European Journal of Immunology|December 18, 2025
Mass Cytometry-Based Approach for the Investigation of Stimulator of Interferon Genes PathwayAnne Reversat, Paul T Kennedy, Anni Georghiou, et al.
Journal for Immunotherapy of Cancer|November 22, 2023
Neuroblastoma: an ongoing cold front for cancer immunotherapyPaul T Kennedy, Demetra Zannoupa, Meong Hi Son, et al.
Immunotherapy Advances|April 23, 2025
CTLA-4-two pathways to anti-tumour immunity?Frank J Ward, Paul T Kennedy, Farah Al-Fatyan, et al.
Cancer Research Communications|December 26, 2023
Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck CancersEmma L Saulters, Paul T Kennedy, Rachel J Carter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2023
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunityPaul T Kennedy, Emma L Saulters, Andrew D Duckworth, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 18, 2021
Zinc Status Alters Alzheimer's Disease Progression through NLRP3-Dependent InflammationJack Rivers-Auty, Victor S Tapia, Claire S White, et al.
EMBO Molecular Medicine|June 23, 2018
A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxiaDaniel E Foxler, Katherine S Bridge, John G Foster, et al.
Pageof 1